课题基金 / 基金详情

COMPREHENSIVE DNA DIAGNOSTIC SYSTEM FOR SINGLE GENE DISORDERS

COMPREHENSIVE DNA DIAGNOSTIC SYSTEM FOR SINGLE GENE DISORDERS
单基因疾病综合 DNA 诊断系统
批准号:
15591080
负责人:
KURE Shigeo
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

KURE Shigeo的其他基金

相似基金

相关文献

中文摘要
翻译
非酮性高甘氨酸血症(NKH)是由线粒体甘氨酸切割系统缺陷引起的,以甘氨酸蓄积为特征。严重者出现昏迷和惊厥,轻度者出现精神发育迟滞和行为异常。甘氨酸在中枢神经系统中蓄积的后果在很大程度上仍然未知。目前尚无有效的治疗方法。我们在一例NKH患者中发现了一个具有显性负效应的GLDC突变。显性阴性GLDC cDNA的转基因表达产生两个小鼠系,其显示脑中甘氨酸水平的显著升高(#10-4 >#5-3)。通过表达正常GLDC还建立了另一个脑甘氨酸耗尽的转基因小鼠系#wP。与野生型C57 BL/6小鼠相比,具有甘氨酸积累的小鼠显示出轻度NKH的行为异常特征,表现为过度活跃(#10 -4)、攻击性(#10-4、#5 - 3)、焦虑(#10-4和#5 - 3)和易癫痫发作(#10-4、#5-3)。与此形成鲜明对比的是,#wP小鼠表现出运动、惊厥和焦虑样活动的显著减少。NMDA受体甘氨酸结合位点的拮抗剂,但不是NMDA受体通道的拮抗剂,可改善高甘氨酸血症小鼠的多动和癫痫易感性。我们的研究结果表明甘氨酸作为一种行为调节剂和一种新的有效治疗轻度NKH的作用。
英文摘要
Nonketotic hyperglycinemia (NKH) is caused by deficiency of the mitochondrial glycine cleavage system, and characterized by accumulation of glycine. Coma and convulsions develop in severe cases while psychomotor retardation and behavioral abnormalities in mild cases. Consequences of glycine accumulation in the central nervous system remain largely unknown. No effective therapy has been established. We identified a GLDC mutation with dominant-negative effect in a patient with NKH. Transgenic expression of the dominant-negative GLDC cDNA generated two mouse lines, which showed significant elevation of glycine level in brain (#10-4 >#5-3). Another transgenic mouse line #wP with depletion of cerebral glycine was also established by expressing normal GLDC. Mice with glycine accumulation showed behavioral abnormalities characteristic to mild NKH, being hyperactive (#10-4), aggressive (#10-4, #5-3), anxious (#10-4 and #5-3), and susceptible to seizures (#10-4, #5-3), as compared with wild type C57BL/6 mice. In sharp contrast, #wP mice showed significant reduction in locomotion, convulsiveness, and anxiety-like activity. Antagonists for the NMDA receptor glycine-binding site, but not an antagonist for the NMDA receptor channel, ameliorated hyperactivity and seizure susceptibility of hyperglycinemic mice. Our results suggest a role of glycine as a behavioral modulator and a novel effective treatment for mild NKH.
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
Matsubara Y, et al.: "Detection of single nudeotide substitution by…"Hum Mutat. 22. 166-172 (2003)
Matsubara Y 等人:“通过……检测单个核苷酸取代”Hum Mutat。22. 166-172 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Glycine decarboxylase mutations : A distinctive phenotype of nonketolic hyperglycinemia in adults.
甘氨酸脱羧酶突变:成人非酮性高甘氨酸血症的独特表型。
DOI: --
发表时间: 2005
期刊: Neurology 64
影响因子: --
作者: [Dinopoulos A, Kure S, Chuck G, Sato S, Gilbert D, Matsubara Y, DeGrauw T.]
通讯作者: DeGrauw T.
DOI: 10.1212/01.wnl.0000158475.12907.d6
发表时间: 2005-04-26
期刊: NEUROLOGY
影响因子: 9.9
作者: [Flusser, H, Korman, SH, Kure, S]
通讯作者: Kure, S
DOI: 10.1111/j.0953-816x.2004.03345.x
发表时间: 2004-05-01
期刊: EUROPEAN JOURNAL OF NEUROSCIENCE
影响因子: 3.4
作者: [Ichinohe, A, Kure, S, Sato, K]
通讯作者: Sato, K
共 16 条
    Genomic analysis of steroid-sensitive nephrotic syndrome using sibling cases
    • 批准号:
      19H03612
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.15万
    • 财政年份:
      2019
    • 负责人:
      KURE Shigeo
    • 依托单位:
    Genetic testing for risk evaluation of Moyamoya disease
    • 批准号:
      25670470
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2013
    • 负责人:
      KURE Shigeo
    • 依托单位:
    Cerebral vascular abnormality in carriers of the RNF213 risk variant detected by a new genetic test
    • 批准号:
      24659486
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      KURE Shigeo
    • 依托单位:
    Development of a genetic test to evaluate the risk for Moyamoya disease
    • 批准号:
      23659512
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      KURE Shigeo
    • 依托单位:
    海外基金